A researcher’s own experiences have led to further understanding of the repair process needed for multiple sclerosis.
Browsing: demyelinating disease
The latest update on the potential accumulation of gadolinium in brain tissue from gadolinium-based contrast agents
Is bone marrow transplantation a viable treatment option for relapsing–remitting MS? Jeffrey Cohen discusses pros and cons of the technique.
A new article suggests that an enzyme deficiency associated with Krabbe’s disease may help provide a better knowledge of mechanisms underlying late-onset neurodegenerative diseases such as Parkinson’s.
Researchers have found that the vitamin D receptor promotes the differentiation of oligodendrocyte progenitor cells and enhances myelin sheath regeneration.
Preclinical study demonstrates that multiple sclerosis nerve repair could be initiated by partial blockade of a cancer-promoting pathway, providing new hope for therapeutics.
Paul Matthews speaks to Ellen Clarke, Commissioning Editor: Paul Matthews, OBE, MD, DPhil, FRCP, FMedSci is Head of the new Division of Brain Sciences at Imperial College, London.